Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Health Catalyst, Inc. Director's Dealing 2021

Feb 17, 2021

33681_dirs_2021-02-16_c20ad3f7-3b96-439b-8310-d37e91f3e362.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-12-31

Reporting Person: KANE JOHN A (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-29 Common Stock G 6000.00 $0.00 Disposed 84466.00 Direct

Footnotes

F1: The shares reported in this transaction represent a bona-fide charitable gift to a Donor Advised Fund.